DCF Advisers’s Sanofi SNY Stock Holding History

DCF Advisers’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-21,000	Closed	-$979K	–	100
2025 Q4	$1.02M	Buy	+21,000	New	+$1.04M	0.27%	66
2025 Q1	–	Sell	-14,500	Closed	-$699K	–	96
2024 Q4	$699K	Buy	14,500 +3,500	+32%	+$178K	0.34%	63
2024 Q3	$634K	Hold	11,000	–	–	0.25%	64
2024 Q2	$534K	Hold	11,000	–	–	0.27%	64
2024 Q1	$535K	Hold	11,000	–	–	0.26%	58
2023 Q4	$547K	Buy	11,000 +1,100	+11%	+$53.8K	0.3%	56
2023 Q3	$531K	Hold	9,900	–	–	0.29%	63
2023 Q2	$534K	Hold	9,900	–	–	0.28%	58
2023 Q1	$539K	Sell	9,900 -4,600	-32%	-$224K	0.33%	46
2022 Q4	$702K	Buy	14,500 +3,492	+32%	+$153K	0.47%	39
2022 Q3	$419K	Buy	+11,008	New	+$491K	0.27%	57

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

DCF Advisers's SNY Position: Q1 2026 in Review

DCF Advisers sold out of Sanofi (SNY) in Q1 2026, closing a stake of 21,000 shares — an estimated $979K sold.

DCF Advisers first reported a position in SNY in Q3 2022 and held it in 11 quarters. The position peaked at $1.02M in Q4 2025. 745 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

DCF Advisers reported no remaining Sanofi position as of Q1 2026 after selling out during the quarter.
DCF Advisers sold 21,000 Sanofi shares in Q1 2026, an estimated $979K.
DCF Advisers first reported a position in Sanofi in Q3 2022 and held it in 11 quarters.
DCF Advisers's Sanofi position peaked at $1.02M in Q4 2025.
745 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on DCF Advisers's 13F filing for Q1 2026, filed 11 May 2026.